PP2A's restraint of mTOR is critical for Treg cell activity

被引：8
|
作者：
Delgoffe, Greg M. [1 ,2 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Tumor Microenvironm Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA
来源：
NATURE IMMUNOLOGY | 2016年 / 17卷 / 05期
关键词：
PHOSPHATASE PP2A; KINASE;
D O I：
10.1038/ni.3442
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Regulatory T cells must limit activation of the metabolic checkpoint kinase mTOR to maintain their identity. The lipid ceramide serves a unique role in this process by inducing phosphatase PP2A-mediated inhibition of the mTORC1 complex.
引用
收藏
页码：478 / 479
页数：3
相关论文
共 44 条
  • [21] PP1C and PP2A are p70S6K Phosphatases Whose Inhibition Ameliorates HLD12-Associated Inhibition of Oligodendroglial Cell Morphological Differentiation
    Matsumoto, Naoto
    Miyamoto, Yuki
    Hattori, Kohei
    Ito, Akihiro
    Harada, Hironori
    Oizumi, Hiroaki
    Ohbuchi, Katsuya
    Mizoguchi, Kazushige
    Yamauchi, Junji
    BIOMEDICINES, 2020, 8 (04)
  • [22] Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models
    Zhang, Huiming
    Wang, Xiaojuan
    Xu, Pu
    Ji, Xuefei
    Chi, Tianyan
    Liu, Peng
    Zou, Libo
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2020, 70 (01) : 29
  • [23] Microcystin-LR (MCLR) Induces a Compensation of PP2A Activity Mediated by α4 Protein in HEK293 Cells
    Li, Tan
    Huang, Pu
    Liang, Jing
    Fu, Wenyu
    Guo, Zonglou
    Xu, Lihong
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2011, 7 (06): : 740 - 752
  • [24] PP2A regulates SCF-induced cardiac stem cell migration through interaction with p38 MAPK
    Wang, Ying
    Xia, Yanli
    Kuang, Dong
    Duan, Yaqi
    Wang, Guoping
    LIFE SCIENCES, 2017, 191 : 59 - 67
  • [25] Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells
    Coles, Garry L.
    Cristea, Sandra
    Webber, James T.
    Levin, Rebecca S.
    Moss, Steven M.
    He, Andy
    Sangodkar, Jaya
    Hwang, Yeonjoo C.
    Arand, Julia
    Drainas, Alexandros P.
    Mooney, Nancie A.
    Demeter, Janos
    Spradlin, Jessica N.
    Mauch, Brandon
    Le, Vicky
    Shue, Yan Ting
    Ko, Julie H.
    Lee, Myung Chang
    Kong, Christina
    Nomura, Daniel K.
    Ohlmeyer, Michael
    Swaney, Danielle L.
    Krogan, Nevan J.
    Jackson, Peter K.
    Narla, Goutham
    Gordan, John D.
    Shokat, Kevan M.
    Sage, Julien
    CANCER CELL, 2020, 38 (01) : 129 - +
  • [26] Ciliary transport regulates PDGF-AA/αα signaling via elevated mammalian target of rapamycin signaling and diminished PP2A activity
    Umberger, Nicole L.
    Caspary, Tamara
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26 (02) : 350 - 358
  • [27] Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
    Hu, Wenting
    Wang, Zhuoqun
    Zhang, Huiliang
    Mahaman, Yacoubou Abdoul Razak
    Huang, Fang
    Meng, Dongli
    Zhou, Ying
    Wang, Shiyi
    Jiang, Nan
    Xiong, Jing
    Westermarck, Jukka
    Lu, Youming
    Wang, Jianzhi
    Wang, Xiaochuan
    Shentu, Yangping
    Liu, Rong
    NEUROTHERAPEUTICS, 2022, 19 (02) : 570 - 591
  • [28] Greatwall-Endosulfine: A Molecular Switch that Regulates PP2A/B55 Protein Phosphatase Activity in Dividing and Quiescent Cells
    Garcia-Blanco, Natalia
    Vazquez-Bolado, Alicia
    Moreno, Sergio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [29] B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling A Complementary Approach To Disrupt Pathological Vessels?
    Ehling, Manuel
    Celus, Ward
    Martin-Perez, Rosa
    Alba-Rovira, Roser
    Willox, Sander
    Ponti, Donatella
    Cid, Maria C.
    Jones, Elizabeth A., V
    Di Conza, Giusy
    Mazzone, Massimiliano
    CIRCULATION RESEARCH, 2020, 127 (06) : 707 - 723
  • [30] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
    Cristobal, I.
    Garcia-Orti, L.
    Cirauqui, C.
    Alonso, M. M.
    Calasanz, M. J.
    Odero, M. D.
    LEUKEMIA, 2011, 25 (04) : 606 - 614
12345